These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 27310203)

  • 1. Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis.
    Cestelli V; Manfredi A; Sebastiani M; Praino E; Cannarile F; Giuggioli D; Ferri C
    Mod Rheumatol; 2017 Jan; 27(1):110-114. PubMed ID: 27310203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longterm effects of endothelin receptor antagonism on microvascular damage evaluated by nailfold capillaroscopic analysis in systemic sclerosis.
    Cutolo M; Zampogna G; Vremis L; Smith V; Pizzorni C; Sulli A
    J Rheumatol; 2013 Jan; 40(1):40-5. PubMed ID: 23118114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Longterm Treatment with Bosentan and Iloprost on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion, and Clinical Status in Systemic Sclerosis.
    Trombetta AC; Pizzorni C; Ruaro B; Paolino S; Sulli A; Smith V; Cutolo M
    J Rheumatol; 2016 Nov; 43(11):2033-2041. PubMed ID: 27744392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with Bosentan and Sildenafil improves Raynaud's phenomenon and fosters the recovery of microvascular involvement in systemic sclerosis.
    Bellando-Randone S; Lepri G; Bruni C; Blagojevic J; Radicati A; Cometi L; De Paulis A; Matucci-Cerinic M; Guiducci S
    Clin Rheumatol; 2016 Jan; 35(1):127-32. PubMed ID: 26631100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bosentan fosters microvascular de-remodelling in systemic sclerosis.
    Guiducci S; Bellando Randone S; Bruni C; Carnesecchi G; Maresta A; Iannone F; Lapadula G; Matucci Cerinic M
    Clin Rheumatol; 2012 Dec; 31(12):1723-5. PubMed ID: 23053682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longterm treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis.
    Cutolo M; Ruaro B; Pizzorni C; Ravera F; Smith V; Zampogna G; Paolino S; Seriolo B; Cimmino M; Sulli A
    J Rheumatol; 2014 May; 41(5):881-6. PubMed ID: 24692525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood perfusion correlates with microvascular abnormalities in systemic sclerosis: a laser-Doppler and nailfold videocapillaroscopy study.
    Cutolo M; Ferrone C; Pizzorni C; Soldano S; Seriolo B; Sulli A
    J Rheumatol; 2010 Jun; 37(6):1174-80. PubMed ID: 20436070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
    Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A
    Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bosentan improves skin perfusion of hands in patients with systemic sclerosis with pulmonary arterial hypertension.
    Rosato E; Molinaro I; Borghese F; Rossi C; Pisarri S; Salsano F
    J Rheumatol; 2010 Dec; 37(12):2531-9. PubMed ID: 20810512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern.
    Manfredi A; Sebastiani M; Campomori F; Pipitone N; Giuggioli D; Colaci M; Praino E; Ferri C
    J Rheumatol; 2016 Aug; 43(8):1575-80. PubMed ID: 27307533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients.
    Sebastiani M; Manfredi A; Colaci M; D'amico R; Malagoli V; Giuggioli D; Ferri C
    Arthritis Rheum; 2009 May; 61(5):688-94. PubMed ID: 19405007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of iloprost on microvascular structure assessed by nailfold videocapillaroscopy: a pilot study.
    Shah P; Murray AK; Moore TL; Herrick AL
    J Rheumatol; 2011 Sep; 38(9):2079-80. PubMed ID: 21885525
    [No Abstract]   [Full Text] [Related]  

  • 13. Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis.
    Sulli A; Soldano S; Pizzorni C; Montagna P; Secchi ME; Villaggio B; Seriolo B; Brizzolara R; Cutolo M
    J Rheumatol; 2009 Jun; 36(6):1235-9. PubMed ID: 19369451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study.
    Sebastiani M; Manfredi A; Vukatana G; Moscatelli S; Riato L; Bocci M; Iudici M; Principato A; Mazzuca S; Del Medico P; De Angelis R; D'Amico R; Vicini R; Colaci M; Ferri C
    Ann Rheum Dis; 2012 Jan; 71(1):67-70. PubMed ID: 21917823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of macro- and micro-angiopathy in scleroderma: An integrated approach combining 22-MHz power Doppler ultrasonography and video-capillaroscopy.
    Schioppo T; Orenti A; Boracchi P; De Lucia O; Murgo A; Ingegnoli F
    Microvasc Res; 2019 Mar; 122():125-130. PubMed ID: 29981761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications.
    Ghizzoni C; Sebastiani M; Manfredi A; Campomori F; Colaci M; Giuggioli D; Ferri C
    Microvasc Res; 2015 May; 99():92-5. PubMed ID: 25842153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital ulcers in scleroderma patients: A retrospective observational study.
    De Cata A; Inglese M; Molinaro F; De Cosmo S; Rubino R; Bernal M; Mazzoccoli G
    Int J Immunopathol Pharmacol; 2016 Jun; 29(2):180-7. PubMed ID: 26684622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis.
    Cutolo M; Sulli A; Pizzorni C; Accardo S
    J Rheumatol; 2000 Jan; 27(1):155-60. PubMed ID: 10648032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible role of iloprost (stable analog of PG12) in promoting neoangiogenesis in systemic sclerosis.
    Faggioli P; Giani L; Mazzone A
    Clin Exp Rheumatol; 2006; 24(2):220-1. PubMed ID: 16762173
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment of patients with severe secondary Raynaud's phenomenon with the endothelin receptor antagonist bosentan.
    Selenko-Gebauer N; Duschek N; Minimair G; Stingl G; Karlhofer F
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii45-8. PubMed ID: 16987835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.